Qureight raises €17.6M Series B backed by Ascension VC, Guinness Ventures and more
Qureight closed its Series B funding round on July 29, 2026. The round included six participating investors: Ascension VC, Guinness Ventures, Hargreave Hale AIM VCT, Meltwind, Molten Ventures, and XTX Ventures. The company has raised €7.8M before, making its total funding €25.6M to date.
Based in the United Kingdom, Qureight delivers AI imaging and analytics to accelerate respiratory drug approvals in the pharmaceutical sector. The company operates within healthcare and life sciences and was co-founded by Muhunthan Thillai and Alessandro Ruggiero.
In the past 12 months, Brouky tracked 269 funding deals in healthcare and life sciences in the UK, with a median deal size of €11.2M.
Related insights
- Stage AnalysisUS Seed Round Counts Rebound in 2025 While Median Sizes Surge Over 2× Since 2023
- Deal SpotlightProject Q raises €15M Series A with Project A Ventures
- Deal SpotlightPreference Models raises €736M Series C with Aditya Agarwal
- Deal SpotlightMicroagi raises €48M seed backed by LocalGlobe, Northzone, Redalpine, Village Global
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.